Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07413757

CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This non-interventional, cross-sectional study aims to investigate treatment preferences from a sample of physicians and patients with experience of 1L EGFR-TKI for stage IV NSCLC by administering a survey, which primarily includes a DCE approach.

Official title: A Cross-sectional Survey-based Study Using Preference Elicitation Method to Assess Decision-making Impact Factor of Chinese Patients and Physicians for First-line EGFR-TKIs Treatment of Stage IV NSCLC (CHOICE)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

590

Start Date

2026-03-02

Completion Date

2026-07-31

Last Updated

2026-03-25

Healthy Volunteers

No

Locations (1)

Research Site

Chengdu, China